Concepedia

Post-immunotherapy Restaging

Post-Immunotherapy Restaging is a clinical assessment protocol that constitutes a systematic reappraisal of cancer stage following the administration of immunotherapeutic interventions to evaluate treatment response, disease progression, or remission within the framework of adaptive cancer management.

7

Publications

602

Citations

51

Authors

36

Institutions

Publications per year

2017–2026

5

Parents

Publications

7

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

Thomas Powles, Laurence Albigès, Axel Bex et al. · Annals of Oncology · 2021 · 200 citations · Full text

, , +16

Factors Explaining Recurrence in Patients Undergoing Chemoimmunotherapy Regimens for Frequently Recurring Superficial Bladder Carcinoma

Eero Kaasinen, Erkki Rintala, Jouko Viitanen et al. · European Urology · 2002 · 154 citations

, , +14

Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT

Tomomi W. Nobashi, Lucia Baratto, Sunil Reddy et al. · Clinical Nuclear Medicine · 2019 · 101 citations

, , +17

Epstein‐Barr virus‐specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma

Julian Huang, Mark H. Fogg, Lori J. Wirth et al. · Cancer · 2017 · 93 citations · Full text

, , +15

Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event

Erica C. Nakajima, Evan J. Lipson, Julie R. Brahmer · Journal of Clinical Oncology · 2019 · 28 citations

, , +14

1–5 of 7

Authors

51

  1. MS
    Manuela Schmidinger

    Medical University of Vienna, Austria

    1 publications · 200 citations

    1

    h-index

  2. SK
    S. K. Hemmatpour

    Southampton General Hospital, United Kingdom

    1 publications · 11 citations

    1

    h-index

  3. JH
    Jochen H. Lorch

    Dana-Farber Cancer Institute, United States

    1 publications · 93 citations

    1

    h-index

  4. TL
    Tapani Liukkonen

    Moisio Hospital, Finland

    1 publications · 154 citations

    1

    h-index

  5. LA
    Laurence Albigès

    Institut Gustave Roussy, France

    1 publications · 200 citations

    1

    h-index

1–5 of 51

Institutions

36

  1. University College London

    London, United Kingdom

    2 h-index

    9 publications

    288 citations

  2. Sidney Kimmel Comprehensive Cancer Center

    Baltimore, United States

    2 h-index

    4 publications

    99 citations

  3. Johns Hopkins University

    Baltimore, United States

    2 h-index

    4 publications

    99 citations

  4. Satakunta Central Hospital

    Pori, Finland

    1 h-index

    1 publications

    154 citations

  5. Dana-Farber Cancer Institute

    Boston, United States

    1 h-index

    6 publications

    558 citations

  6. Stanford University

    Stanford, United States

    1 h-index

    2 publications

    202 citations

  7. Vall d'Hebron Institute of Oncology

    Barcelona, Spain

    1 h-index

    1 publications

    200 citations

  8. Medical University of Vienna

    Vienna, Austria

    1 h-index

    1 publications

    200 citations

1–8 of 36

Venues

  1. Annals of Oncology

    1 publications · 200 citations

    1

    h-index

  2. Cancer

    1 publications · 93 citations

    1

    h-index

  3. European Urology

    1 publications · 154 citations

    1

    h-index

  4. Clinical Nuclear Medicine

    CNM · 1 publications · 101 citations

    1

    h-index

  5. Clinical Lung Cancer

    1 publications · 15 citations

    1

    h-index

1–5